Uganda Faces Rising Threat of Crimean-Congo Hemorrhagic Fever
A confirmed case of Crimean-Congo hemorrhagic fever (CCHF) has been reported in Kyankwanzi District, central Uganda, marking the first case in the country for 2026. The patient, a 21-year-old male nurse, initially sought care for symptoms including headache, fever, and loss of appetite, which rapidly progressed to more severe manifestations.
Understanding Crimean-Congo Hemorrhagic Fever
CCHF is a widespread viral disease transmitted by ticks and, occasionally, through contact with infected animal blood or tissues. The virus, belonging to the Nairovirus genus of the Bunyaviridae family, can cause severe hemorrhagic fever with a case fatality rate ranging from 10-40%.
The initial symptoms, as seen in the recent Ugandan case, can mimic other febrile illnesses. However, CCHF quickly escalates, often presenting with non-bloody diarrhea, vomiting, joint pain, conjunctivitis, chest pain, and unexplained bleeding from the nose and gums. Early diagnosis and supportive care are crucial, but no licensed vaccine currently exists.
The Role of Ticks and Livestock
The lifecycle of the CCHF virus relies heavily on ticks, particularly those of the Hyalomma genus. Animals become infected through tick bites, and the virus persists in their bloodstream for approximately one week, facilitating further transmission. This creates a tick-animal-tick cycle. Individuals involved in the livestock industry – agricultural workers, slaughterhouse employees, and veterinarians – are at heightened risk.
Uganda’s Recent CCHF History
While this is the first confirmed case in 2026, Uganda has experienced CCHF outbreaks in recent years. In 2024, the country reported 11 cases (7 confirmed) and three deaths across four districts: Kasese, Kiruhuru, Kyankwanzi, and Lyantonde. This highlights the ongoing challenge of CCHF in the region.
Public Health Response and Contact Tracing
Following the confirmation of the case in Kyankwanzi, Ugandan health authorities have initiated a comprehensive response. This includes isolating the patient, providing supportive treatment, and conducting thorough investigations. Eight contacts have been identified and are currently under follow-up in Kyankwanzi and neighboring Kiboga District. Active case searching and alert verification are as well underway.
Future Trends and Potential Risks
Several factors suggest the potential for increased CCHF incidence in the future. Climate change is expanding the geographic range of tick vectors, bringing them into contact with fresh populations. Changes in land use, such as deforestation and agricultural expansion, can also disrupt ecosystems and increase human-animal interactions, raising the risk of transmission. Increased international travel and trade could potentially contribute to the spread of the virus to new areas.
Enhanced surveillance systems, like the one established in Uganda in 2013 with assistance from the CDC, are vital for early detection and rapid response. Continued investment in diagnostic capabilities, public health infrastructure, and community education will be essential to mitigate the threat of CCHF.
FAQ
What are the symptoms of CCHF? Symptoms include fever, headache, muscle aches, vomiting, diarrhea, and bleeding.
How is CCHF transmitted? CCHF is transmitted by ticks or through contact with infected animal blood or tissues.
Is there a vaccine for CCHF? No, there is currently no licensed vaccine for CCHF.
What is the case fatality rate of CCHF? The case fatality rate ranges from 10-40%.
What should I do if I suspect I have CCHF? Seek immediate medical attention and inform your healthcare provider of any potential exposure to ticks or infected animals.
Related News:
- Uganda: Anthrax outbreak in Lyantonde District results in 4 deaths
- Chikungunya outbreak in Seychelles prompts travel warning
- Rift Valley fever outbreak in Mauritania appears to be under control
Related reading
